JENNIFER BULLARD: Open Payments
NPI 1659912731 · CLINTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 46 payments from 27 companies in 2025. Trend: 2023 $306 · 2024 $1,007 · 2025 $936
Food & beverage: $936
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $176 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $69 |
| Alexion Pharmaceuticals, Inc. | 3 | $65 |
| Ardelyx, Inc. | 3 | $57 |
| Grifols USA, LLC | 2 | $45 |
| Amgen Inc. | 3 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| ABIOMED | 1 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
Products named: Ozempic, JARDIANCE, ULTOMIRIS, FARXIGA, IBSRELA, Prolastin-C Liquid, OTEZLA, VOQUEZNA.
Industry payments across TN — which companies pay providers there.
